SCOTUS denies cert in skinny label appeal from the Federal Circuit | Allen & Overy LLP

On May 15, 2023, the Supreme Court of the United States denied Teva Pharmaceuticals USA, Inc.’s (“Teva”) petition for certiorari in Teva Pharmaceuticals USA, Inc. v. GlaxoSmithKline,...

Related Keywords

United States ,Delaware ,Teva Pharms ,Smithkline Beecham Cork Ltd ,Supreme Court ,Majority Holding ,United States Inc ,Allen Overy ,Teva Pharmaceuticals United States Inc ,Teva Pharmaceuticals United States ,Smithkline Beecham ,Reissue Patent ,Federal Circuit ,Judge Prost ,Solicitor General ,Abbreviated New Drug Application ,Orange Book ,